Company intelligence / Profile preview
Anaeropharma Science
Chiyoda City, Tokyo Prefecture, Japananaeropharma.co.jp ↗
- Ownership
- Private
- Employees
- ~16
- Development stage
- Other
01
Overview
Anaeropharma Science specializes in developing novel anti-cancer therapeutics that target the hypoxic environment within solid tumors using proprietary recombinant bifidobacterium technology. Their lead programs have reached preclinical stages, with one program for metastatic solid tumors suspended. The company’s approach represents a unique bacterial therapy platform for cancer treatment but has not yet advanced to clinical trials or commercialization.
- Therapeutic areas
- Oncology
- Modalities
- Gene therapyBispecific antibodyBacterial therapy (recombinant bifidobacterium)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
No major pharmaceutical partnerships specifically named in public sources; general mention of cooperation with pharmaceutical industry
Beyond the preview
Go deeper on Anaeropharma Science.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anaeropharma Science.